Purchase Order 75N95021P00528

Award Date 9/9/21
Potential Completion Date 8/8/22
Potential Value $681K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $471,850 firm fixed price purchase order to Medkoo Biosciences for a small molecule library. The library will contain 52 specific compounds requested in the solicitation to support NCATS' Early Translation Branch pre-clinical screening and research efforts. The library must be delivered to the NIH location in Bethesda, Maryland within one year of the September 2022 award date....
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $141,500 firm-fixed-price purchase order to Chemdiv, Inc. for the acquisition of an 11,000 compound methyltransferase library. This non-competitive award was made under simplified acquisition procedures without a set-aside designation. The contract required delivery of the compound library within 8 weeks. Chemdiv, Inc. is a for-profit organization providing drug...
This is a $376,706 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business located in New Jersey. The contract supports the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program, providing chemical compounds and other scientific inputs for the agency's biomedical research initiatives....
This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...
The National Center for Advancing Translational Sciences, a component of the U.S. Department of Health and Human Services' National Institutes of Health, awarded a $22,226.00 firm fixed price purchase order to MedChemExpress LLC, a New Jersey-based provider of life science research materials. The contract is to obtain 5-milligram samples of biologically active small molecules with well-defined mechanisms of action. This material will be used to create the MIPE 5.1 molecular library, a collection...
Medchemexpress LLC was awarded a firm fixed price purchase order valued at seventy-seven thousand one hundred ninety-three dollars and forty-one cents ($77,193.41) by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to deliver one chemical library of five hundred nine bioactive compounds. The award originated from a sources sought notice issued by the National Institutes of Health's National Center for Advancing Translational...
The federal contract award HHSN271201500037A, valued at $498,000.00, was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Chemdiv, Inc., a for-profit organization based in San Diego, California, to provide small molecule compounds to support the National Center for Advancing Translational Sciences (NCATS) Pharmacologically Active Chemical Toolbox...
This is a federal purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), a civilian federal agency. The $12,800.00 firm fixed-price contract was awarded to Wuxi Apptec (Hongkong) Limited, a for-profit limited liability company, to obtain 5 small molecule compound libraries. The contract has no set-aside designation and the ultimate completion date is October 9, 2021. Wuxi Apptec is a global...
This firm fixed-price purchase order contract, valued at $54,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health (NIH), to Pharmaron, Inc. Pharmaron is a minority-owned, for-profit Subcontinent Asian (Asian-Indian) American contract research organization that specializes in preclinical drug discovery and development services. The contract is for testing 20 small molecule compounds in rat pharmacokinetic...

This federal contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Medkoo Inc., doing business as Medkoo Biosciences. The $680,550 firm fixed price purchase order is for the delivery of the NCATS Library of Small Molecules, containing 14 specific small molecule compounds with validated biological activity to support high-throughput and high-content screening efforts.

This contract was not set aside for any socioeconomic program. Medkoo is classified as a minority-owned business and an Asian-Pacific American-owned business. The company has previously been awarded other NIH contracts for providing small molecule libraries and compounds to support pre-clinical research across NCATS and the National Institute on Drug Abuse. This latest award demonstrates Medkoo's expertise in supplying specialized chemical reagents to federal agencies for use in pharmaceutical and biomedical research.

Generated 5/24/24, 10:53 AM